DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+16.06%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$126M
AUM Growth
+$126M
(+27%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
9.87%
Top 10 Holdings %
Top 10 Hldgs %
54.03%
Holding
70
New
10
Increased
16
Reduced
10
Closed
8
Top Buys
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$3.36M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.1M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$2.1M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
$1.7M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$1.67M |
Top Sells
| 1 |
XNPT
XENOPORT, INC.
XNPT
|
$1.25M |
| 2 |
BLUE
bluebird bio
BLUE
|
$1.15M |
| 3 |
Neurocrine Biosciences
NBIX
|
$1.04M |
| 4 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
$1.03M |
| 5 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$846K |
Sector Composition
| 1 | Healthcare | 59.53% |
| 2 | Financials | 0.92% |
